SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-094304
Filing Date
2020-08-13
Accepted
2020-08-13 06:50:20
Documents
56
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2020489-1_10q.htm 10-Q 635925
2 EXHIBIT 31.1 tm2020489d1_ex31-1.htm EX-31.1 10216
3 EXHIBIT 32.1 tm2020489d1_ex32-1.htm EX-32.1 5519
  Complete submission text file 0001104659-20-094304.txt   5396222

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT lptx-20200630.xml EX-101.INS 1285608
5 XBRL TAXONOMY EXTENSION SCHEMA lptx-20200630.xsd EX-101.SCH 48678
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lptx-20200630_cal.xml EX-101.CAL 46979
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lptx-20200630_def.xml EX-101.DEF 181256
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20200630_lab.xml EX-101.LAB 464096
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20200630_pre.xml EX-101.PRE 335732
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 201097142
SIC: 2834 Pharmaceutical Preparations